CF Carriers May Also Be at Higher Risk for Asthma, Especially Those in Asia

Patricia Inácio, PhD avatar

by Patricia Inácio, PhD |

Share this article:

Share article via email
inhaled antibiotic murepavadin

Individuals carrying the mutated gene for cystic fibrosis (CF) show an increased risk for asthma, in particular CF carriers from Asian countries. The study, “Risk of asthma in heterozygous carriers for cystic fibrosis: A meta-analysis,” was published in the Journal of Cystic Fibrosis.

People with CF are known to have a higher prevalence for asthma compared to the general population. However, it remains unclear whether heterozygous carriers of CF are also susceptible to asthma. Previous studies reported an association between CF heterozygous carriers and an elevated asthma risk, while others found no such link.  (Heterozygous carriers have only one mutated CFTR gene [Cystic Fibrosis Transmembrane conductance Regulator], not the two mutations found in patients. These people are disease-free, but can pass CF to future generations.)

Researchers tackled this question, performing a meta-analysis on published literature (between 1966 and 2015) to determine the risk of asthma in CF heterozygotes when compared to non-carriers. The search was performed in PubMed and Embase databases.

The Cystic Fibrosis News Today forums are a place to connect with other patients, share tips and talk about the latest research. Join today!

For the purpose of the study, asthma was assessed either by physician’s diagnosis or as a result of a questionnaire about self-reported asthma, recurrent wheeze, and asthma symptoms. Studies where asthma was determined by a physician were considered of higher quality. Additionally, studies with adults instead of children, and including more than 500 subjects, were evaluated as being of higher quality.

In total, 15 studies comprising 2,113 asthma cases and 13,457 controls were included in the meta-analysis.

The collected data showed that CF heterozygotes also carry a higher risk for asthma development, compared to non-carriers. This trend was maintained in those studies considered of high quality.

Additionally, researchers found that the risk for developing asthma in individuals heterozygous for CF was higher in studies performed in Asian countries, compared to those conducted in European countries. This suggests that potential environmental, social and demographic factors in Asian countries may contribute to this trend. Large cohort studies, however, are required to fully assess this hypothesis.